Inspire Medical Systems (INSP)
(Delayed Data from NYSE)
$191.48 USD
+5.13 (2.75%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $191.38 -0.10 (-0.05%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$191.48 USD
+5.13 (2.75%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $191.38 -0.10 (-0.05%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth B Momentum B VGM
Zacks News
Buy 3 Medical Info Systems Stocks to Brave Industry-wide Challenges
by Urmimala Biswas
Stocks like 10x Genomics Inc. (TXG), Omnicell, Inc. (OMCL) and Inspire Medical Systems, Inc. (INSP) are expected to gain despite pandemic-led disruptions.
Inspire Medical Systems (INSP) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inspire (INSP) delivered earnings and revenue surprises of 21.31% and 17.95%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Will Inspire Medical Systems (INSP) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inspire (INSP) delivered earnings and revenue surprises of 7.69% and 9.18%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Inspire Medical Systems (INSP) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inspire (INSP) delivered earnings and revenue surprises of 37.78% and 10.18%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
NextGen (NXGN) Solution Acts as Financial Bridge Amid COVID-19
by Zacks Equity Research
NextGen's (NXGN) cloud-based EHR platform, NextGen Office, enables specialty practices to improve their financial performance during the pandemic.
Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FNY
Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FNY
Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FNY
Inspire Medical Systems (INSP) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inspire (INSP) delivered earnings and revenue surprises of 45.07% and 59.33%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Medical Products Earnings Due on Nov 2: STE, HSIC & More
by Urmimala Biswas
Several medical product stocks have come up with bullish earnings reports so far this reporting cycle. Let's see how STE, HSIC, PACB, INSP are poised ahead of their announcements.
Analysts Estimate Inspire Medical Systems (INSP) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inspire Medical Systems (INSP) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inspire (INSP) delivered earnings and revenue surprises of 18.52% and 39.71%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Inspire Medical Systems (INSP) Q2 Earnings Expected to Decline
by Zacks Equity Research
Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inspire (INSP) delivered earnings and revenue surprises of -17.54% and 0.03%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Inspire Medical (INSP) This Earnings Season?
by Zacks Equity Research
Inspire Medical (INSP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Inspire Medical Systems (INSP) Stock Might be a Great Pick
by Zacks Equity Research
Inspire Medical Systems (INSP) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Inspire Medical Systems (INSP) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inspire (INSP) delivered earnings and revenue surprises of 9.52% and 12.62%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Why Inspire Medical Systems (INSP) Might Surprise This Earnings Season
by Zacks Equity Research
Inspire (INSP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Inspire Medical Systems (INSP) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inspire (INSP) delivered earnings and revenue surprises of 20.93% and 8.94%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Inspire Medical Systems (INSP) Q3 Earnings Expected to Decline
by Zacks Equity Research
Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inspire Medical Systems (INSP) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inspire (INSP) delivered earnings and revenue surprises of 28.89% and 8.96%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Inspire Medical Systems (INSP) Q2 Earnings Expected to Decline
by Zacks Equity Research
Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Inspire (INSP) delivered earnings and revenue surprises of 10.26% and 13.24%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?